Figure 1.
Study participants for the overall vaccine effectiveness and the vaccine effectiveness by time since vaccination against SARS-CoV-2 infection
Individuals who were tested by reverse transcriptase-PCR(RT-PCR) or rapid antigen (RTK-Ag) or RT-PCR only, between September 1, 2021, to December 31, 2021, and fully vaccinated with homologous BNT162b2 or unvaccinated between September 1, 2021, and November 30, 2021, aged 12 to 17 years and had no confirmed SARS-CoV-2 infections before the outcomes observed.